CD8A and neoplasm: Immune checkpoint inhibitors modulate the interaction between immune cells, including CD4+ and CD8+ T-cells, B-cells, macrophages, dendritic cells (DCs), tumor-infiltrating lymphocytes (TILs), and tumor cells [10,11].